Homocysteinemia is widely accepted as an independent risk factor for coronary and peripheral vascular disease. Quatrefolic®, as a source of active folate, is an important regulator of Hcy metabolism.
What does homocysteine have to do with folate?
Homocysteine (Hcy) is a common amino acid found in the bloodstream that serves as a critical intermediate in methylation cycle reactions.
A disruption of Hcy metabolism, with an increased risk of several pathologies, occurs when Hcy levels are greater than normal.
Quatrefolic® offers tangible advantages versus folic acid and can promote healthier heart life – better folate blood levels directly translate to lower Hcy levels, especially for people with MTHFR (methylenetetrahydrofolate reductase) polymorphism, which is approximately 40% of the global population. These genetic alterations can lead to an increase in homocysteine blood levels.
Gnosis maintains wide attention on what science supports on Hcy and folate: low levels of 5-MTHF, critically contribute to increasing circulating Hcy levels and a toxic accumulation in the bloodstream.
Latest news & videos
- Mobility & Joint
- News
- Quatrefolic®
- Sep 02, 2024
Optimal Folate Intake in Elderly Women May Help Reduce Osteoporosis Risk
Research has shown that up to 20% of bone loss can occur during menopause,...
- MenaQ7®
- Mobility & Joint
- News
- Aug 29, 2024
MenaQ7® Matrix K2: A Perfect Fit in Magnesium Formulations
Our latest stability data shows MenaQ7® Matrix is the perfect choice when combining the...
- News
- Quatrefolic®
- Reproduction & Women
- Aug 27, 2024
New Quatrefolic® Educational Video
Although folate and folic acid are often used interchangeably, they are not the same...
